Abstract
Understanding the pathways guiding the development of definitive hematopoiesis with lymphoid potential is essential for advancing human pluripotent stem cell (hPSC) technologies for the treatment of blood diseases and immunotherapies. In the embryo, lymphoid progenitors and hematopoietic stem cells (HSCs) arise from hemogenic endothelium (HE) lining arteries but not veins. Here, we show that activation of the arterial program through ETS1 overexpression or by modulating MAPK/ERK signaling pathways at the mesodermal stage of development dramatically enhanced the formation of arterial-type HE expressing DLL4 and CXCR4. Blood cells generated from arterial HE were more than 100-fold enriched in T cell precursor frequency and possessed the capacity to produce B lymphocytes and red blood cells expressing high levels of BCL11a and β-globin. Together, these findings provide an innovative strategy to aid in the generation of definitive lymphomyeloid progenitors and lymphoid cells from hPSCs for immunotherapy through enhancing arterial programming of HE. Park et al. find that activation of the arterial program through ETS1 overexpression or by modulating MAPK/ERK signaling pathways at the mesodermal stage of development dramatically enhances formation of arterial-type hemogenic endothelium (HE) from hPSCs. Blood cells generated from arterial HE are highly enriched in definitive lymphomyeloid progenitors.
Original language | English (US) |
---|---|
Pages (from-to) | 2467-2481 |
Number of pages | 15 |
Journal | Cell reports |
Volume | 23 |
Issue number | 8 |
DOIs | |
State | Published - May 22 2018 |
Externally published | Yes |
Bibliographical note
Funding Information:We thank Matthew Raymond for editorial assistance. This work was supported by funds from the NIH ( R01HL116221 , U01HL099773 , U01HL134655 , and P51 RR000167 ), and The Charlotte Geyer Foundation .
Publisher Copyright:
© 2018 The Author(s)
Keywords
- ETS1
- MAPK/ERK signaling
- T cells
- hematopoiesis
- hematopoietic stem cells
- hemogenic endothelium
- human pluripotent stem cells